Faculty

Institution

Unit

Venue

Robiya Joseph

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Gynecologic Oncology And Reproductive Medicine

Department Of Gynecologic Research

The University of Texas MD Anderson Cancer Center

NoneRobiya Joseph is currently serving as a Gynecologic Oncology And Reproductive Medicine faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robiya Joseph

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology cancer research cancer biology cell biology tumor biology immunology medicinal research pharmacology metastasis cancer cells breast cancer cancer treatment molecular biology cancer immunotherapy oncogenes cellular therapy gynecologic oncology cancer genomics molecular cancer tumor targeting therapeutic targets cancer discovery cancer care cancer genetics cell regulation stem cell research pharmacotherapy cell research cancer growth melanoma cancer stem cells metastatic melanoma regenerative medicine vascular biology tumor suppressors adaptive immune system immune checkpoint inhibitors genitourinary cancers endometrial cancer epithelial-mesenchymal transition leukemia enzyme inhibition brain tumor research redox biology cancer risk anti-cancer agents rna biology cellular immune responses pharmaceutical chemistry pharmaceutical sciences pharmaceutical care wound care pharmaceutical practice analytical biotechnology cellular structure cell motility novel therapies tumor heterogeneity immunomodulation skin cancer oncogenic agent chemoprevention strategies lymphoid neoplasia lymphatic system pan-cancer analysis epithelial-mesenchymal transition genes triple-negative breast cancer drug sensitivity prostate cancer cells stem-cell properties mesenchymal-epithelial transition extracellular vesicles breast cancer cells single-cell cloning microtubule dynamics uncontrolled extravasation

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract A045: Overcoming Platelet-Mediated Immune Suppression in Ovarian Cancer. Cancer Immunology Research (2026)

immunologyabstract a045blood plateletgynecologic oncologycancer immunotherapycellular therapygynecologic cancersthrombopoiesisgynecologyovarian cancerimmunotherapy

Abstract P2-06-04: Potential Impact of the Cancer-Associated Fibroblast Secretome in the Tumor Microenvironment. Clinical Cancer Research (2025)

potential impactcancer-associated fibroblast secretomecancer researchmolecular cancercancer cellstumor microenvironmentcancer biologypathologytumor biologybiological microenvironmentscell biology

Emt-Induced Stem Cell and Mesenchymal Programs Can Be Decoupled via Cell Division and Esrp1-Dependent Mechanisms. iScience (2025)

stem cell researchemt-induced stem celladult stem cellscell signalingcell divisionstem-cell therapystem cellscancer cellsdevelopmental biologyesrp1-dependent mechanismscell biology

Abstract 3847: Dual Targeting of Egfl6 and Vegf-a to Overcome Immune Suppression in Ovarian Cancer. Cancer Research (2024)

Sujanitha UmamaheswaranLingegowda S. MangalaRobiya JosephNicholas B. JenningsMark S. KimYunfei WenEmine BayraktarNingyan ZhangZhiqiang AnAnil K. Sood

immunologycancer researchcancer biologyovarian cancerimmune suppression

Epha2- and Hdac-Targeted Combination Therapy in Endometrial Cancer. International Journal of Molecular Sciences (2024)

Robiya JosephSantosh K. DasariSujanitha UmamaheswaranLingegowda S. MangalaEmine BayraktarCristian Rodriguez-AguayoYutuan WuNghi NguyenReid T. PowellMary SobieskiYuan LiuMark Seungwook KimSara CorvignoKatherine FosterPahul HanjraThanh Chung VuMamur A. ChowdhuryPaola AmeroClifford StephanGabriel Lopez-BeresteinShannon N. WestinAnil K. Sood

gynecologic oncologynovel therapiestumor heterogeneitygynecologytumor targetingmolecular scienceendometrial cancerhdac-targeted combination therapytumor suppressorscancer immunotherapytherapeutic targetsgynecologic cancerscancer treatmenttumor biologycancer discoverybiomolecular engineeringmolecular biologyoncologyoncogenescancer cells

Mechanism and Rational Combinations With Gp ‐2250, a Novel Oxathiazine Derivative, in Ovarian Cancer. Cancer Medicine (2024)

pharmacologytherapeutic targetcancer researchgynecologic oncologynovel oxathiazine derivativecancer discoverycancer cellanti-cancer agentendocrine-related canceroncogenic agentchemoprevention strategiescancer letterrational combinationsovarian cancerbiochemistry

Abstract 528: Mechanisms and Rational Combinations With Gp-2250, a Novel Oxathiazine Derivative, in Ovarian Cancer. Cancer Research (2023)

Mark S. KimDeanna GlassmanAdrian Lankenau AhumadaEmine BayraktarNicholas B. JenningsRobiya JosephSanghoon LeeRobert L. ColemanAnil K. Sood

cancer researchgynecologic oncologycancer biologynovel oxathiazine derivativeovarian cancerbiochemistry

Combination of Epha2- and Wee1-Targeted Therapies in Endometrial Cancer. International Journal of Molecular Sciences (2023)

Santosh K. DasariRobiya JosephSujanitha UmamaheswaranLingegowda S. MangalaEmine BayraktarCristian Rodriguez-AguayoYutuan WuNghi NguyenReid T. PowellMary SobieskiYuan LiuMamur A. ChowdhuryPaola AmeroClifford StephanGabriel Lopez-BeresteinShannon N. WestinAnil K. Sood

tumor targetingpharmacologycancer researchgynecologic oncologytherapeutic targetsmolecular biologyoncologymedicinal researchcancer treatmentgynecologyendometrial cancer

S100A8/S100A9 Integrates F-Actin and Microtubule Dynamics to Prevent Uncontrolled Extravasation of Leukocytes. Biomedicines (2023)

immunologycellular structurecellular physiologycytoskeletoncell motilitymicrotubule dynamicscell signalinguncontrolled extravasationmolecular cell biologycell biology

Supplementary Data From Rational Combination of Crm1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models. (2023)

Katelyn F. HandleyCristian Rodriguez-AguayoShaolin MaElaine SturRobiya JosephEmine BayraktarSantosh K. DasariNghi NguyenReid T. PowellMary SobieskiCristina IvanMark KimSujanitha UmamaheswaranDeanna GlassmanYunfei WenPaola AmeroClifford StephanRobert L. ColemanYosef LandesmanShannon N. WestinPrahlad T. RamAnil K. Sood

mouse modelspharmacologysupplementary dataradiation oncologygynecologic oncologyfunctional selectivityrational combinationoncologycancer biologytumor biologyovarian cancerhealth sciences

1
2
3
4
10 / page

Robiya Joseph

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Gynecologic Oncology And Reproductive Medicine

Department Of Gynecologic Research

The University of Texas MD Anderson Cancer Center

NoneRobiya Joseph is currently serving as a Gynecologic Oncology And Reproductive Medicine faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robiya Joseph

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract A045: Overcoming Platelet-Mediated Immune Suppression in Ovarian Cancer. Cancer Immunology Research (2026)

immunologyabstract a045blood plateletgynecologic oncologycancer immunotherapycellular therapygynecologic cancersthrombopoiesisgynecologyovarian cancerimmunotherapy

Abstract P2-06-04: Potential Impact of the Cancer-Associated Fibroblast Secretome in the Tumor Microenvironment. Clinical Cancer Research (2025)

potential impactcancer-associated fibroblast secretomecancer researchmolecular cancercancer cellstumor microenvironmentcancer biologypathologytumor biologybiological microenvironmentscell biology

Emt-Induced Stem Cell and Mesenchymal Programs Can Be Decoupled via Cell Division and Esrp1-Dependent Mechanisms. iScience (2025)

stem cell researchemt-induced stem celladult stem cellscell signalingcell divisionstem-cell therapystem cellscancer cellsdevelopmental biologyesrp1-dependent mechanismscell biology

Abstract 3847: Dual Targeting of Egfl6 and Vegf-a to Overcome Immune Suppression in Ovarian Cancer. Cancer Research (2024)

Sujanitha UmamaheswaranLingegowda S. MangalaRobiya JosephNicholas B. JenningsMark S. KimYunfei WenEmine BayraktarNingyan ZhangZhiqiang AnAnil K. Sood

immunologycancer researchcancer biologyovarian cancerimmune suppression

Epha2- and Hdac-Targeted Combination Therapy in Endometrial Cancer. International Journal of Molecular Sciences (2024)

Mechanism and Rational Combinations With Gp ‐2250, a Novel Oxathiazine Derivative, in Ovarian Cancer. Cancer Medicine (2024)

Abstract 528: Mechanisms and Rational Combinations With Gp-2250, a Novel Oxathiazine Derivative, in Ovarian Cancer. Cancer Research (2023)

Mark S. KimDeanna GlassmanAdrian Lankenau AhumadaEmine BayraktarNicholas B. JenningsRobiya JosephSanghoon LeeRobert L. ColemanAnil K. Sood

cancer researchgynecologic oncologycancer biologynovel oxathiazine derivativeovarian cancerbiochemistry

Combination of Epha2- and Wee1-Targeted Therapies in Endometrial Cancer. International Journal of Molecular Sciences (2023)

tumor targetingpharmacologycancer researchgynecologic oncologytherapeutic targetsmolecular biologyoncologymedicinal researchcancer treatmentgynecologyendometrial cancer

S100A8/S100A9 Integrates F-Actin and Microtubule Dynamics to Prevent Uncontrolled Extravasation of Leukocytes. Biomedicines (2023)

immunologycellular structurecellular physiologycytoskeletoncell motilitymicrotubule dynamicscell signalinguncontrolled extravasationmolecular cell biologycell biology

Supplementary Data From Rational Combination of Crm1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models. (2023)

mouse modelspharmacologysupplementary dataradiation oncologygynecologic oncologyfunctional selectivityrational combinationoncologycancer biologytumor biologyovarian cancerhealth sciences

1
2
3
4
10 / page